Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19317822 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
Conditions: Diabetes Mellitus Type 2;   Metabolic Syndrome;   Cardiovascular Disease;   Diastolic Dysfunction;   Fatty Liver
Intervention: Drug: Liraglutide

Indicates status has not been verified in more than two years